BCM
Burrage Capital Management Portfolio holdings
AUM
$99.7M
This Quarter Return
+0.22%
1 Year Return
+65.92%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$127M
AUM Growth
+$127M
(-11%)
Cap. Flow
-$2.11M
Cap. Flow
% of AUM
-1.66%
Top 10 Holdings %
Top 10 Hldgs %
64.99%
Holding
29
New
3
Increased
12
Reduced
4
Closed
2
Top Buys
| 1 |
Assembly Biosciences
ASMB
|
$3.29M |
| 2 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$1.71M |
| 3 |
Aurinia Pharmaceuticals
AUPH
|
$1.56M |
| 4 |
EPZM
Epizyme, Inc
EPZM
|
$1.33M |
| 5 |
CALT
Calliditas Therapeutics AB American Depositary Shares
CALT
|
$265K |
Top Sells
| 1 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$3.94M |
| 2 |
Adverum Biotechnologies
ADVM
|
$3.26M |
| 3 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$1.68M |
| 4 |
Korro Bio
KRRO
|
$1.34M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
$553K |
Sector Composition
| 1 | Healthcare | 90.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EPZM
1
DELISTED
Epizyme, Inc
EPZM
| $12M | 9.44% | 1,002,528 +111,251 | +12% | +$1.33M |
|
|
AIMT
2
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $11.5M | 9.04% | 332,546 | – | – |
|
3
MEI Pharma
MEIP
$160M
| $9.48M | 7.49% | 3,039,038 +37,888 | +1% | +$118K |
|
|
ISEE
4
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $8.44M | 6.66% | 1,495,515 +18,644 | +1% | +$105K |
|
5
PTC Therapeutics
PTCT
$3.92B
| $8.11M | 6.4% | 173,545 -5,841 | -3% | -$273K |
|
6
OrthoPediatrics
KIDS
$536M
| $7.88M | 6.22% | 171,607 +2,139 | +1% | +$98.2K |
|
7
NeoGenomics
NEO
$1.13B
| $7.11M | 5.61% | 192,671 +2,466 | +1% | +$91K |
|
|
TPTX
8
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $6.82M | 5.39% | 78,118 +946 | +1% | +$82.6K |
|
9
Cytokinetics
CYTK
$4.23B
| $5.73M | 4.53% | 264,859 +3,368 | +1% | +$72.9K |
|
|
10
Aurinia Pharmaceuticals
AUPH
$1.58B
| $5.34M | 4.21% | 362,383 +105,945 | +41% | +$1.56M |
|
11
Insmed
INSM
$28.8B
| $5.32M | 4.2% | 165,400 | – | – |
|
12
AnaptysBio
ANAB
$569M
| $4.88M | 3.85% | 330,549 +2,435 | +0.7% | +$35.9K |
|
13
Y-mAbs Therapeutics
YMAB
$388M
| $4.72M | 3.73% | 123,025 | – | – |
|
14
ADC Therapeutics
ADCT
$345M
| $4.45M | 3.51% | 134,912 | – | – |
|
15
Crinetics Pharmaceuticals
CRNX
$2.92B
| $3.78M | 2.98% | 241,278 +4,884 | +2% | +$76.5K |
|
|
16
Assembly Biosciences
ASMB
$190M
| $3.29M | 2.6% | +200,000 | New | +$3.29M |
|
17
Regenxbio
RGNX
$451M
| $3.2M | 2.53% | 116,405 +1,405 | +1% | +$38.7K |
|
|
GTHX
18
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.64M | 2.08% | 228,597 -145,279 | -39% | -$1.68M |
|
|
19
Korro Bio
KRRO
$217M
| $2.58M | 2.03% | 134,141 -69,776 | -34% | -$1.34M |
|
20
Apellis Pharmaceuticals
APLS
$3.48B
| $2.32M | 1.83% | 76,804 +2,352 | +3% | +$71K |
|
21
Fulcrum Therapeutics
FULC
$351M
| $2.31M | 1.83% | 291,645 | – | – |
|
|
TCDA
22
DELISTED
Tricida, Inc. Common Stock
TCDA
| $1.71M | 1.35% | +188,182 | New | +$1.71M |
|
23
Merus
MRUS
$4.98B
| $1.68M | 1.33% | 140,176 | – | – |
|
|
ZGNX
24
DELISTED
Zogenix, Inc.
ZGNX
| $703K | 0.56% | 39,189 -30,811 | -44% | -$553K |
|
|
KDNY
25
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $330K | 0.26% | 135,898 | – | – |
|